Printer Friendly

ChungJin Biotech Develops a New Electro-Stimulation Bee Venom Collector and World's First Digital Honeybee Artificial Insemination Instrument.

SEOUL, South Korea -- ChungJin Biotech Co., Ltd, a manufacturer of Bee Venom Collector and fluid bed granulation coating machines in South Korea, announced today that they have developed a new electro-stimulation Bee Venom Collator and the world's first Honeybee Artificial Insemination Instrument with integrated digital screen. Along with their development, the company also announced that they will begin global marketing with these products, focusing on Europe and Latin America.

ChungJin's new Bee Venom Collector extracts bee-venom through an electrical shock to a live bee, while minimizing the time spent for the electricity of 12V for the shock. As a result, the death rate of the bees used in the machine is reduced significantly. Also, it uses safety glass, stainless, and enhanced plastic material in order to achieve superb safety, durability, and lightweight convenience for producers at bee farms.

ChungJin's new Honeybee artificial Insemination Instrument extracts sperm from drones and artificially inseminates the queen for breeding honeybees and improving the quality of honeybee produced. For the first time in the world, ChungJin's new Honeybee artificial Insemination Instrument has the microscope function with digital screen in order record the artificial insemination process for educational purposes for variety of users. It can also replay the process continuously for more effective employee training and significant reduction of errors during the artificial insemination process.

ChungJin Biotech had exhibited Bee Venom Collector and digital Honeybee artificial Insemination Instrument at '2008 World Artificial Insemination Symposium' in Puerto Vallarta, Mexico from October 15th to 19th.

Starting from the opening day, ChungJin's booth was visited by Ney Gonzalez, the Nayarit State governor of Mexico and numerous buyers. Based on the popularity of their exhibition, ChungJin was published in two of the respected local newspapers, "Siempre Libres (Headline: Presentan Tecnologia de Punta de Koreanos / 16 OCT, 2008)" and "Noticias (Headline: Los mexicanos necesitamos mover la economia / 16 OCT, 2008)", and successfully reached agreements with a variety of buyers during the symposium.

Choul-Koo Kim, CEO and president of ChungJin Biotech, said, "Compared to current products in the market, ChungJin's new Bee Venom Collector provide very efficient bee venom collection by minimizing the damages to the bees and therefore generate more profits for the bee farms. Also, ChungJin`s Honeybee artificial Insemination Instrument is integrated with digital media device, which helps saving the cost for the machine since it doesn't require any additional devices for the insemination process."

"Because of the side effects from abusing antibiotics, there are numerous researches around the world to find the replacement for it. Bee Venoms are well known as natural antibiotics, which means that there is a great potential for bee venoms market and lots of opportunities ahead of us," he added.

About ChungJin Biotech Co., Ltd

Established in 2004, ChungJin Biotech is the leading developer of Bee Venom Collectors and Honeybee Artificial Insemination Instrument in the world. Based on their successful developments, Chung-Jin Biotech has been expanding its brand to the global market including Europe, Latin American, and South East Asia. For more information about Chung-Jin Biotech, please visit www.biovenom.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 31, 2008
Words:507
Previous Article:NeoPhotonics Ranked Number Four in Deloitte's 2008 "Technology Fast 50" for Silicon Valley Internet, Media & Entertainment and Communication...
Next Article:AIG Excess Casualty(R) Launches Paperless Policy Issuance Service.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters